Consensus Bio-Rad Laboratories, Inc.

Stocks

BIO

US0905722072

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 13:12:20 2026-10-12 EDT			5-day change	1st Jan Change
360.00 ^USD	-1.68%		-5.16%	+18.89%

09-24	Bio-Rad Laboratories, Inc. Presents at Bernstein Insights: Healthcare Leaders and Disruptors ? 3rd Annual Healthcare Forum, Sep-24-2026 08:50 AM
09-09	Bio-Rad Laboratories, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 03:45 PM

Evolution of the Average Target: Bio-Rad Laboratories, Inc.

Evolution of the Target Price: Bio-Rad Laboratories, Inc.

Changes in Analyst Recommendations: Bio-Rad Laboratories, Inc.

b36150c5eb6.Kt39adZntZpFoJhzyts1kxPPn8HxYh8DUOyhb6yeyQI.SIiqNrAo3Oox7ewlraJQ92Wm-oK6KVFPA7XjX-HapGZFqpMaiSrW9A7qyQ~67888a3e8997864e237fe70cfa5d59b4

Analysts' recommendations: Bio-Rad Laboratories, Inc.

08-07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
08-05	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT
05-15	Bio-Rad Laboratories' Sales Growth Set to Recover in 2027, RBC Says	MT
04-07	Citigroup Downgrades Bio-Rad Laboratories to Neutral From Buy, Adjusts Price Target to $300 From $375	MT
02-13	UBS Adjusts Price Target on Bio-Rad Laboratories to $335 From $350, Maintains Buy Rating	MT
25-10-30	Analyst recommendations: Boeing, Alphabet, Caterpillar, Chipotle, Wayfair…
25-09-03	RBC Raises Price Target on Bio-Rad Laboratories to $437 From $409, Keeps Outperform Rating	MT
25-08-01	UBS Adjusts Price Target on Bio-Rad Laboratories to $325 From $310, Maintains Buy Rating	MT
25-08-01	RBC Raises Price Target on Bio-Rad Laboratories to $409 From $387, Keeps Outperform Rating	MT
25-07-01	RBC Raises Price Target on Bio-Rad Laboratories to $387 From $381, Keeps Outperform Rating	MT
25-05-02	UBS Adjusts Price Target on Bio-Rad Laboratories to $310 From $355, Maintains Buy Rating	MT
25-05-02	RBC Cuts Price Target on Bio-Rad Laboratories to $392 From $409, Keeps Outperform Rating	MT
25-04-08	RBC Cuts Price Target on Bio-Rad Laboratories to $409 From $430, Keeps Outperform Rating	MT
25-02-14	UBS Adjusts Price Target on Bio-Rad Laboratories to $355 From $390, Keeps Buy Rating	MT
25-02-14	RBC Cuts Price Target on Bio-Rad Laboratories to $447 From $477, Keeps Outperform Rating	MT
25-02-04	RBC Trims Price Target on Bio-Rad Laboratories to $477 From $481, Keeps Outperform Rating	MT
24-12-09	RBC Raises Price Target on Bio-Rad Laboratories to $481 From $469, Keeps Outperform Rating	MT
24-10-31	UBS Adjusts Price Target on Bio-Rad Laboratories to $390 From $400, Maintains Buy Rating	MT
24-10-01	Citigroup Upgrades Bio-Rad Laboratories to Buy From Neutral, Adjusts Price Target to $400 From $350	MT
24-09-13	RBC Raises Price Target on Bio-Rad Laboratories to $446 From $401, Keeps Outperform Rating	MT
24-08-28	Wells Fargo Initiates Bio-Rad Laboratories at Equalweight With $340 Price Target	MT
24-08-02	Citigroup Adjusts Price Target on Bio-Rad Laboratories to $350 From $300	MT
24-08-02	UBS Adjusts Price Target on Bio-Rad Laboratories to $400 From $385, Maintains Buy Rating	MT
24-08-02	RBC Trims Price Target on Bio-Rad Laboratories to $401 From $402, Keeps Outperform Rating	MT
24-06-24	RBC Trims Price Target on Bio-Rad Laboratories to $402 From $414, Keeps Outperform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Objective/dr gap
BIO-RAD LABORATORIES, INC.	-	-10.33%
ABBOTT LABORATORIES		+21.2%
MEDTRONIC PLC		+18.04%
STRYKER CORPORATION		+31.33%
ESSILORLUXOTTICA		+53.03%
CENCORA, INC.		+14.22%
HOYA CORPORATION		+20.53%
BECTON, DICKINSON AND COMPANY		+5.62%
IDEXX LABORATORIES, INC.		+35.39%
MEDLINE INC.		+22.51%
Average		+21.16%
Weighted average by Cap.		+24.26%